Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-12

Clinical Trial Update: Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating muscadine grape skin extract in patients with advanced/metastatic/unresectable malignant neoplasms; study completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Muscadine grape skin extract

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm | Phase 1 | Status: COMPLETED | Results posted: 2019-09-12